Liang 2005.
Methods | Eight‐week, (likely) randomised study. |
Participants | In‐ and out‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 30 participants. Fluoxetine: 30 participants. Citalopram dose range: 10‐60 mg/day. Fluoxetine: dose range: 10‐40 mg/day. |
Outcomes | Change in Hamilton Depression Rating Scale 24 Item (HDRS‐24) from baseline to endpoint, number of patients who responded to treatment. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |